首页> 外国专利> USE OF ACANTHOPANAX TRIFOLIATUS POLYSACCHARIDE ATP1-1 IN PREPARATION OF DRUGS FOR TREATMENT OF DIABETES

USE OF ACANTHOPANAX TRIFOLIATUS POLYSACCHARIDE ATP1-1 IN PREPARATION OF DRUGS FOR TREATMENT OF DIABETES

机译：acanthopanax trifoliatus多糖ATP1-1制备用于治疗糖尿病的药物

页面导航

摘要
著录项
相似文献

摘要

A method of treating diabetes includes the step of preparing Acanthopanax trifoliatus polysaccharide ATP1-1 into drugs for treating the diabetes. The Acanthopanax trifoliatus polysaccharide ATP1-1 can alleviate the symptoms of weight loss in diabetic mice and facilitate the weight increase of mice; ATP1-1 has a hypoglycemic effect on the diabetic mice, and can enhance the ability to control blood glucose, reduce blood glucose fluctuation, and achieve the effect of treating diabetes; ATP1-1 can effectively reverse the decrease of insulin caused by injury of pancreatic islet; ATP1-1 has various degrees of therapeutic effects on mice pancreatic islets and can inhibit apoptosis of pancreatic islet cells; ATP1-1 can effectively repair injury of a spleen and regulate the body's immunologic function.

机译：一种治疗糖尿病的方法包括将 acanthopanax Trifoliatus 多糖ATP1-1中的步骤中的步骤中的用于治疗糖尿病的药物。 acanthopanax trifoliatus 多糖ATP1-1可以缓解糖尿病小鼠体重减轻的症状，并促进小鼠的重量增加; ATP1-1对糖尿病小鼠有降血糖作用，可以增强控制血糖，降低血糖波动的能力，实现治疗糖尿病的效果; ATP1-1可以有效地逆转胰岛损伤引起的胰岛素的降低; ATP1-1对小鼠胰岛胰岛具有各种疗效，并且可以抑制胰岛细胞的凋亡; ATP1-1可以有效地修复脾脏损伤并调节身体的免疫功能。

著录项

公开/公告号US2021187008A1

专利类型
公开/公告日2021-06-24

原文格式PDF
申请/专利权人 GUANGDONG PHARMACEUTICAL UNIVERSITY;
展开▼

申请/专利号US202017262774
发明设计人 YUFANG PAN;
展开▼

申请日2020-01-15
分类号A61K31/715;A61P3/10;
国家 US
入库时间 2022-08-24 19:32:39

相似文献

专利
外文文献
中文文献